The Chief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Ravi Dadhich has launched Sitagliptin a new variant of medicines for diabetes at affordable prices for all under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. PMBI included new variants of medicines Sitagliptin and its combination in its all Jan Aushdhi Kendras viz.

Name of the Product for Pack of 10

(1) Sitagliptin Phosphate Tablet IP 50mg Rs 60

(2) Sitagliptin Phosphate Tablet IP 100mg Rs 100

(3) Sitagliptin + Metformin Hydrochloride Tablets 50mg/500mg Rs 65

(4) Sitagliptin + Metformin Hydrochloride Tablets 50mg/1000mg Rs 70

Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. All these variants are available at 60% to 70% lesser prices than branded variants as they are available in price band of Rs 162 to Rs 258 at other medical stores.

Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling quality generic medicines, surgical equipment, nutraceuticals and other products. At present, these Kendras make available more than 1600 medicines and 250 surgical devices.